ATE369846T1 - Verwendung von 1,3-propanediol derivaten - Google Patents

Verwendung von 1,3-propanediol derivaten

Info

Publication number: ATE369846T1
Authority: AT; Austria
Prior art keywords: optionally substituted; propanediol derivatives; chem; independently; compound
Prior art date: 1996-11-19

Application number

AT02025422T

Other languages

English (en)

Inventor

Sylvain Cottens

Robert Paul Hof

Roland Wenger

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-19

Filing date

1997-11-17

Publication date

2007-09-15

1997-11-17 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2007-09-15 Application granted granted Critical

2007-09-15 Publication of ATE369846T1 publication Critical patent/ATE369846T1/de

Links

DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical class C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 title 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
150000003839 salts Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Microbiology (AREA)
Mycology (AREA)
Oncology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Light Receiving Elements (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polyurethanes Or Polyureas (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT02025422T 1996-11-19 1997-11-17 Verwendung von 1,3-propanediol derivaten ATE369846T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9624038.7A GB9624038D0 (en)	1996-11-19	1996-11-19	Organic compounds

Publications (1)

Publication Number	Publication Date
ATE369846T1 true ATE369846T1 (de)	2007-09-15

Family

ID=10803173

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT02025422T ATE369846T1 (de)	1996-11-19	1997-11-17	Verwendung von 1,3-propanediol derivaten
AT97951219T ATE275947T1 (de)	1996-11-19	1997-11-17	Neue verwendung von 1,3-propanediol derivaten

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT97951219T ATE275947T1 (de)	1996-11-19	1997-11-17	Neue verwendung von 1,3-propanediol derivaten

Country Status (24)

Country	Link
US (3)	US6274629B1 (de)
EP (2)	EP0941082B1 (de)
JP (2)	JP4004070B2 (de)
CN (2)	CN1293876C (de)
AT (2)	ATE369846T1 (de)
AU (1)	AU728420B2 (de)
BR (1)	BR9713105A (de)
CA (1)	CA2270952C (de)
CZ (1)	CZ174999A3 (de)
DE (2)	DE69730727T2 (de)
DK (1)	DK1312359T3 (de)
ES (2)	ES2289041T3 (de)
GB (1)	GB9624038D0 (de)
HU (1)	HUP0000343A3 (de)
ID (1)	ID21568A (de)
IL (1)	IL129824A (de)
NO (1)	NO992259L (de)
NZ (1)	NZ335629A (de)
PL (1)	PL190348B1 (de)
PT (2)	PT941082E (de)
RU (1)	RU2217136C2 (de)
SI (1)	SI1312359T1 (de)
SK (1)	SK284806B6 (de)
WO (1)	WO1998022100A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2237970T3 (es)	1998-11-11	2005-08-01	Novartis Ag	Produccion de 2-amino-2-(2-(4-alquil c2-20-fenil)etil)propano-1,3-dioles.
HRP20050176A2 (en) *	1999-12-16	2005-08-31	Teva Pharmaceutical Industries Ltd.	Novel processes for making - and a new crystalline form of-leflunomide
EP1315735A4 (de)	2000-08-31	2005-04-06	Merck & Co Inc	Phosphat-derivate als immunoregulatorische verbindungen
US20040087662A1 (en) *	2001-02-22	2004-05-06	Marc Bigaud	Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
DE60208180T2 (de) *	2001-04-20	2006-08-17	Debiopharm S.A.	Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung
JP4476623B2 (ja) *	2001-06-08	2010-06-09	ノバルティスアーゲー	インスリン産生細胞移植片拒絶の処置または予防
GB0117921D0 (en) *	2001-07-23	2001-09-12	Novartis Ag	Organic compounds
US7780993B2 (en) *	2001-09-07	2010-08-24	Yeda Research And Development Co. Ltd.	Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
US20040136972A1 (en) *	2001-09-07	2004-07-15	Yeda Research And Development Co. Ltd.	Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
GB0125443D0 (en)	2001-10-23	2001-12-12	Novartis Ag	Organic Compounds
DE60328161D1 (de)	2002-01-11	2009-08-13	Daiichi Sankyo Co Ltd	Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung
GB0217777D0 (en) *	2002-07-31	2002-09-11	Novartis Ag	Organic compounds
IL165425A0 (en) *	2004-11-28	2006-01-15	Yeda Res & Dev	Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
BRPI0409250B8 (pt)	2003-04-08	2022-01-18	Mitsubishi Pharma Corp	Composições farmacêuticas sólidas compreendendo um agonista receptor de s1p e um álcool do açúcar
US7524887B2 (en)	2003-06-06	2009-04-28	Sanofi-Aventis Deutschland Gmbh	2-amino-1,3-propanediol compounds for the treatment of acute pain
EP1484057A1 (de) *	2003-06-06	2004-12-08	Aventis Pharma Deutschland GmbH	Verwendung von 2-amino-1,3-propandiolderivaten zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen
US7838562B2 (en) *	2003-06-24	2010-11-23	University Of Connecticut	Methods of inhibiting vascular permeability and apoptosis
US7074659B2 (en) *	2003-11-13	2006-07-11	Volterra Semiconductor Corporation	Method of fabricating a lateral double-diffused MOSFET (LDMOS) transistor
WO2005079788A1 (ja)	2004-02-24	2005-09-01	Sankyo Company, Limited	アミノアルコール化合物
US20080096972A1 (en) *	2004-07-30	2008-04-24	Thitiwan Buranachokpaisan	Compound formulations of 2-amino-1, 3-propanediol compounds
KR101346527B1 (ko) *	2005-12-15	2013-12-31	미쓰비시 타나베 파마 코퍼레이션	아민 화합물 및 그 의약 용도
AR085749A1 (es)	2011-04-01	2013-10-23	Novartis Ag	Formulaciones
RU2496486C1 (ru)	2012-07-11	2013-10-27	Александр Васильевич Иващенко	Фармацевтическая композиция с улучшенной сыпучестью, лекарственное средство, способ получения и применение
JP6484567B2 (ja) *	2013-03-05	2019-03-13	バイオコン・リミテッドＢｉｏｃｏｎＬｉｍｉｔｅｄ	２−アミノ−１，３−プロパンジオール化合物およびその塩の製造のための方法
WO2017046345A1 (en)	2015-09-18	2017-03-23	Sanovel Ilac Sanayi Ve Ticaret A.S.	Fingolimod capsule composition
EP4353709A4 (de) *	2021-05-31	2026-02-18	Shanghai Yonsun Biotechnology Co Ltd	Pharmazeutisches salz von fingolimod, herstellungsverfahren dafür, pharmazeutische zusammensetzung damit und verwendung davon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3904679A (en) *	1972-05-23	1975-09-09	Upjohn Co	15-Methyl and 15-ethyl prostaglandin F{HD 2{331 {0 {B analogs
US6136310A (en) *	1991-07-25	2000-10-24	Idec Pharmaceuticals Corporation	Recombinant anti-CD4 antibodies for human therapy
BR9206313A (pt) *	1991-07-25	1995-04-11	Idec Pharma Corp	Anticorpos recombinantes para terapia humana.
US5747034A (en) *	1992-07-09	1998-05-05	Chiron Corporation	Methods and materials for the induction of T cell anergy
GB9221220D0 (en) *	1992-10-09	1992-11-25	Sandoz Ag	Organic componds
WO1994008943A1 (fr) *	1992-10-21	1994-04-28	Yoshitomi Pharmaceutical Industries, Ltd.	Compose 2-amino-1,3-propanediol et immunosuppresseur
HU224814B1 (en) *	1995-12-28	2006-02-28	Mitsubishi Pharma Corp	Use of propane-1,3-diol derivative for the preparation of a medicament useful for the topical treating of inflammatory and immune diseases
US6476004B1 (en) *	1996-07-18	2002-11-05	Mitsubishi Pharma Corporation	Pharmaceutical composition
JP2002241272A (ja) *	1996-07-18	2002-08-28	Mitsubishi Pharma Corp	医薬処方組成物
KR20000075745A (ko) *	1997-02-27	2000-12-26	가마후라 아키오	의약 조성물

1996
- 1996-11-19 GB GBGB9624038.7A patent/GB9624038D0/en active Pending
1997
- 1997-11-17 RU RU99112577/14A patent/RU2217136C2/ru not_active IP Right Cessation
- 1997-11-17 AT AT02025422T patent/ATE369846T1/de not_active IP Right Cessation
- 1997-11-17 PT PT97951219T patent/PT941082E/pt unknown
- 1997-11-17 EP EP97951219A patent/EP0941082B1/de not_active Expired - Lifetime
- 1997-11-17 US US09/308,098 patent/US6274629B1/en not_active Expired - Lifetime
- 1997-11-17 AU AU54831/98A patent/AU728420B2/en not_active Ceased
- 1997-11-17 WO PCT/EP1997/006408 patent/WO1998022100A2/en not_active Ceased
- 1997-11-17 ES ES02025422T patent/ES2289041T3/es not_active Expired - Lifetime
- 1997-11-17 CN CNB2004100059961A patent/CN1293876C/zh not_active Expired - Fee Related
- 1997-11-17 AT AT97951219T patent/ATE275947T1/de not_active IP Right Cessation
- 1997-11-17 NZ NZ335629A patent/NZ335629A/en unknown
- 1997-11-17 EP EP02025422A patent/EP1312359B1/de not_active Expired - Lifetime
- 1997-11-17 PL PL97333463A patent/PL190348B1/pl not_active IP Right Cessation
- 1997-11-17 SI SI9730772T patent/SI1312359T1/sl unknown
- 1997-11-17 ID IDW990370A patent/ID21568A/id unknown
- 1997-11-17 ES ES97951219T patent/ES2227726T3/es not_active Expired - Lifetime
- 1997-11-17 DK DK02025422T patent/DK1312359T3/da active
- 1997-11-17 CZ CZ991749A patent/CZ174999A3/cs unknown
- 1997-11-17 HU HU0000343A patent/HUP0000343A3/hu unknown
- 1997-11-17 PT PT02025422T patent/PT1312359E/pt unknown
- 1997-11-17 CA CA002270952A patent/CA2270952C/en not_active Expired - Fee Related
- 1997-11-17 CN CNB971998582A patent/CN1146411C/zh not_active Expired - Fee Related
- 1997-11-17 SK SK659-99A patent/SK284806B6/sk unknown
- 1997-11-17 DE DE69730727T patent/DE69730727T2/de not_active Expired - Fee Related
- 1997-11-17 BR BR9713105-9A patent/BR9713105A/pt not_active Application Discontinuation
- 1997-11-17 DE DE69738033T patent/DE69738033T2/de not_active Expired - Fee Related
- 1997-11-17 JP JP52320098A patent/JP4004070B2/ja not_active Expired - Fee Related
- 1997-11-17 IL IL12982497A patent/IL129824A/xx not_active IP Right Cessation
1999
- 1999-05-10 NO NO992259A patent/NO992259L/no unknown
2001
- 2001-07-03 US US09/898,143 patent/US6486209B2/en not_active Expired - Fee Related
2002
- 2002-09-30 US US10/261,536 patent/US20030069315A1/en not_active Abandoned
2004
- 2004-05-21 JP JP2004152002A patent/JP2004256554A/ja active Pending

Also Published As

Publication number	Publication date
RU2217136C2 (ru)	2003-11-27
IL129824A0 (en)	2000-02-29
HUP0000343A3 (en)	2001-06-28
GB9624038D0 (en)	1997-01-08
EP1312359A3 (de)	2004-01-02
JP2004256554A (ja)	2004-09-16
WO1998022100A2 (en)	1998-05-28
AU728420B2 (en)	2001-01-11
US20030069315A1 (en)	2003-04-10
PT1312359E (pt)	2007-11-09
US6274629B1 (en)	2001-08-14
PL190348B1 (pl)	2005-11-30
DK1312359T3 (da)	2007-10-08
DE69738033D1 (de)	2007-09-27
CA2270952A1 (en)	1998-05-28
DE69730727D1 (de)	2004-10-21
CN1237906A (zh)	1999-12-08
EP0941082B1 (de)	2004-09-15
SK284806B6 (sk)	2005-11-03
ID21568A (id)	1999-06-24
ES2289041T3 (es)	2008-02-01
EP0941082A2 (de)	1999-09-15
CN1293876C (zh)	2007-01-10
US20010056124A1 (en)	2001-12-27
HK1022639A1 (en)	2000-08-18
JP4004070B2 (ja)	2007-11-07
CN1146411C (zh)	2004-04-21
CZ174999A3 (cs)	1999-08-11
NO992259D0 (no)	1999-05-10
NO992259L (no)	1999-05-10
DE69738033T2 (de)	2008-04-30
EP1312359A2 (de)	2003-05-21
SI1312359T1 (sl)	2008-08-31
PL333463A1 (en)	1999-12-20
ES2227726T3 (es)	2005-04-01
IL129824A (en)	2003-07-31
SK65999A3 (en)	1999-12-10
PT941082E (pt)	2004-12-31
CA2270952C (en)	2007-09-18
NZ335629A (en)	2001-09-28
US6486209B2 (en)	2002-11-26
DE69730727T2 (de)	2005-09-22
JP2001503780A (ja)	2001-03-21
CN1515253A (zh)	2004-07-28
AU5483198A (en)	1998-06-10
HUP0000343A2 (hu)	2000-12-28
EP1312359B1 (de)	2007-08-15
BR9713105A (pt)	2000-04-11
WO1998022100A3 (en)	1998-06-25
ATE275947T1 (de)	2004-10-15

Legal Events

Date

Code

Title

Description

2007-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1312359

Country of ref document: EP

2010-08-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE369846T1 (de)	2007-09-15	Verwendung von 1,3-propanediol derivaten
ATE125539T1 (de)	1995-08-15	1,4-benzothiazedinderivat.
ATE263771T1 (de)	2004-04-15	Totalsynthese von acylfulvenen mit antitumorwirkung
EA200100310A1 (ru)	2001-10-22	Кислородсодержащие гетероциклические соединения
DE69505470D1 (de)	1998-11-26	Pyrrolocarbazol
ES2065994T3 (es)	1995-03-01	Beta-dicetonas substituidas.
AU635445B2 (en)	1993-03-18	New compounds
DK415789A (da)	1990-02-27	Tetracykliske antidepressive midler
BR8606955A (pt)	1987-11-03	Processo para preparar uma composicao,concentrado aditivo,composicao lubrificante,composicao combustivel e metodo para reduzir o consumo de combustivel
FI845102L (fi)	1985-06-23	Imidazo/1,2-c/pyrimidiner.
ATE116290T1 (de)	1995-01-15	4,5-polymethylen-4-isothiazolin-3-on-derivate mit biocider wirkung.
ATE120745T1 (de)	1995-04-15	Imidazochinolonderivate.
DE69200862D1 (de)	1995-01-26	N-2-Chlorbenzyl-2-oxo- und N-2-Chlorbenzyl-2,2,-dioxo-1,2,3-Oxathiazolidinderivate, ihre Herstellung und ihre Verwendung in der Synthese von Thieno[3,2-c]pyridinderivaten.
DE69103985D1 (de)	1994-10-20	N-Alkylthiazolidinderivate.
ES2077697T3 (es)	1995-12-01	Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.